David C. Smithson
Impact in
-
- Cancer-related Molecular Pathways
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Receptor Mechanisms and Signaling 2
- Plant-derived Lignans Synthesis and Bioactivity 2
-
- Synthesis and Biological Evaluation 5
- Co-authors
- R. Kiplin Guy (12 shared papers)Anang A. Shelat (7 shared papers)Fangyi Zhu (6 shared papers)P. Michael Conn (4 shared papers)Jo Ann Janovick (4 shared papers)Michael A. Dyer (2 shared papers)Aart G. Jochemsen (1 shared paper)C.A. Regni (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Assay and Drug Development Technologies (2 papers)Journal of Natural Products (2 papers)Journal of Biological Chemistry (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
David C. Smithson
19 papers receiving 530 citations
Peers
Comparison fields: 5 of 92
- Oncology 166
- Biotechnology 52
- Molecular Biology 328
- Organic Chemistry 100
- Cell Biology 51
Countries citing papers authored by David C. Smithson
This map shows the geographic impact of David C. Smithson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Smithson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Smithson more than expected).
Fields of papers citing papers by David C. Smithson
This network shows the impact of papers produced by David C. Smithson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Smithson. The network helps show where David C. Smithson may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Smithson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 159 | |
| 2 | 2010 | 66 | |
| 3 | 2012 | 46 | |
| 4 | 2014 | 35 | |
| 5 | 2010 | 33 | |
| 6 | 2017 | 29 | |
| 7 | 2013 | 25 | |
| 8 | 2013 | 23 | |
| 9 | 2018 | 18 | |
| 10 | 2015 | 17 | |
| 11 | 2013 | 17 | |
| 12 | 2013 | 16 | |
| 13 | 2010 | 15 | |
| 14 | 2013 | 14 | |
| 15 | 2013 | 11 | |
| 16 | 2009 | 8 | |
| 17 | 2010 | 6 | |
| 18 | 2016 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About David C. Smithson
David C. Smithson is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 542 indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (5 papers), Research on Leishmaniasis Studies (4 papers), Trypanosoma species research and implications (4 papers), Cancer Research and Treatments (2 papers), Receptor Mechanisms and Signaling (2 papers), Cancer-related Molecular Pathways (2 papers), Plant-derived Lignans Synthesis and Bioactivity (2 papers) and Berberine and alkaloids research (2 papers). The work is most often cited by research in Oncology (166 citations), Biotechnology (52 citations), Molecular Biology (328 citations), Organic Chemistry (100 citations) and Cell Biology (51 citations). David C. Smithson has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include R. Kiplin Guy, Anang A. Shelat, Fangyi Zhu, P. Michael Conn, Jo Ann Janovick, Michael A. Dyer, Aart G. Jochemsen, C.A. Regni, Damon R. Reed and Brenda A. Schulman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Assay and Drug Development Technologies, Journal of Natural Products, Journal of Biological Chemistry and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.